Global Point-of-care Infectious Disease Diagnostics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Point-of-care Infectious Disease Diagnostics market size was valued at US$ million in 2023. With growing demand in downstream market, the Point-of-care Infectious Disease Diagnostics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Point-of-care Infectious Disease Diagnostics market. Point-of-care Infectious Disease Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Point-of-care Infectious Disease Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Point-of-care Infectious Disease Diagnostics market.
Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Point-of-care Infectious Disease Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Point-of-care Infectious Disease Diagnostics market. It may include historical data, market segmentation by Type (e.g., HIV POC, Clostridium Difficile POC), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Point-of-care Infectious Disease Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Point-of-care Infectious Disease Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Point-of-care Infectious Disease Diagnostics industry. This include advancements in Point-of-care Infectious Disease Diagnostics technology, Point-of-care Infectious Disease Diagnostics new entrants, Point-of-care Infectious Disease Diagnostics new investment, and other innovations that are shaping the future of Point-of-care Infectious Disease Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Point-of-care Infectious Disease Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Point-of-care Infectious Disease Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Point-of-care Infectious Disease Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Point-of-care Infectious Disease Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Point-of-care Infectious Disease Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Point-of-care Infectious Disease Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Point-of-care Infectious Disease Diagnostics market.
Market Segmentation:
Point-of-care Infectious Disease Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Point-of-care Infectious Disease Diagnostics market size was valued at US$ million in 2023. With growing demand in downstream market, the Point-of-care Infectious Disease Diagnostics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Point-of-care Infectious Disease Diagnostics market. Point-of-care Infectious Disease Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Point-of-care Infectious Disease Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Point-of-care Infectious Disease Diagnostics market.
Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Point-of-care Infectious Disease Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Point-of-care Infectious Disease Diagnostics market. It may include historical data, market segmentation by Type (e.g., HIV POC, Clostridium Difficile POC), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Point-of-care Infectious Disease Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Point-of-care Infectious Disease Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Point-of-care Infectious Disease Diagnostics industry. This include advancements in Point-of-care Infectious Disease Diagnostics technology, Point-of-care Infectious Disease Diagnostics new entrants, Point-of-care Infectious Disease Diagnostics new investment, and other innovations that are shaping the future of Point-of-care Infectious Disease Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Point-of-care Infectious Disease Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Point-of-care Infectious Disease Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Point-of-care Infectious Disease Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Point-of-care Infectious Disease Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Point-of-care Infectious Disease Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Point-of-care Infectious Disease Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Point-of-care Infectious Disease Diagnostics market.
Market Segmentation:
Point-of-care Infectious Disease Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- HIV POC
- Clostridium Difficile POC
- HBV POC
- Respiratory Syncytial Virus POC
- HPV POC
- Influenza/Flu POC
- HCV POC
- MRSA POC
- TB and Drug-Resistant TB POC
- Hospitals
- Clinics
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher Scientific
- Abbott
- Calypte Biomedical
- Chembio Diagnostic Systems
- Meridian Bioscience
- MedMira
- Trinity Biotech
- Sekisui Diagnostics
- OraSure Technologies
- Quidel
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Point-of-care Infectious Disease Diagnostics Market Size 2019-2030
2.1.2 Point-of-care Infectious Disease Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Point-of-care Infectious Disease Diagnostics Segment by Type
2.2.1 HIV POC
2.2.2 Clostridium Difficile POC
2.2.3 HBV POC
2.2.4 Respiratory Syncytial Virus POC
2.2.5 HPV POC
2.2.6 Influenza/Flu POC
2.2.7 HCV POC
2.2.8 MRSA POC
2.2.9 TB and Drug-Resistant TB POC
2.3 Point-of-care Infectious Disease Diagnostics Market Size by Type
2.3.1 Point-of-care Infectious Disease Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Point-of-care Infectious Disease Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Home
2.4.4 Assisted Living Healthcare Facilities
2.4.5 Laboratories
2.4.6 Others
2.5 Point-of-care Infectious Disease Diagnostics Market Size by Application
2.5.1 Point-of-care Infectious Disease Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2019-2024)
3 POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Point-of-care Infectious Disease Diagnostics Market Size Market Share by Players
3.1.1 Global Point-of-care Infectious Disease Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Point-of-care Infectious Disease Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS BY REGIONS
4.1 Point-of-care Infectious Disease Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Point-of-care Infectious Disease Diagnostics Market Size Growth (2019-2024)
4.3 APAC Point-of-care Infectious Disease Diagnostics Market Size Growth (2019-2024)
4.4 Europe Point-of-care Infectious Disease Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024)
5.2 Americas Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024)
5.3 Americas Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point-of-care Infectious Disease Diagnostics Market Size by Region (2019-2024)
6.2 APAC Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024)
6.3 APAC Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Point-of-care Infectious Disease Diagnostics by Country (2019-2024)
7.2 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024)
7.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST
10.1 Global Point-of-care Infectious Disease Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Point-of-care Infectious Disease Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Point-of-care Infectious Disease Diagnostics Forecast
10.1.3 APAC Point-of-care Infectious Disease Diagnostics Forecast
10.1.4 Europe Point-of-care Infectious Disease Diagnostics Forecast
10.1.5 Middle East & Africa Point-of-care Infectious Disease Diagnostics Forecast
10.2 Americas Point-of-care Infectious Disease Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Point-of-care Infectious Disease Diagnostics Market Forecast
10.2.2 Canada Point-of-care Infectious Disease Diagnostics Market Forecast
10.2.3 Mexico Point-of-care Infectious Disease Diagnostics Market Forecast
10.2.4 Brazil Point-of-care Infectious Disease Diagnostics Market Forecast
10.3 APAC Point-of-care Infectious Disease Diagnostics Forecast by Region (2025-2030)
10.3.1 China Point-of-care Infectious Disease Diagnostics Market Forecast
10.3.2 Japan Point-of-care Infectious Disease Diagnostics Market Forecast
10.3.3 Korea Point-of-care Infectious Disease Diagnostics Market Forecast
10.3.4 Southeast Asia Point-of-care Infectious Disease Diagnostics Market Forecast
10.3.5 India Point-of-care Infectious Disease Diagnostics Market Forecast
10.3.6 Australia Point-of-care Infectious Disease Diagnostics Market Forecast
10.4 Europe Point-of-care Infectious Disease Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Point-of-care Infectious Disease Diagnostics Market Forecast
10.4.2 France Point-of-care Infectious Disease Diagnostics Market Forecast
10.4.3 UK Point-of-care Infectious Disease Diagnostics Market Forecast
10.4.4 Italy Point-of-care Infectious Disease Diagnostics Market Forecast
10.4.5 Russia Point-of-care Infectious Disease Diagnostics Market Forecast
10.5 Middle East & Africa Point-of-care Infectious Disease Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Point-of-care Infectious Disease Diagnostics Market Forecast
10.5.2 South Africa Point-of-care Infectious Disease Diagnostics Market Forecast
10.5.3 Israel Point-of-care Infectious Disease Diagnostics Market Forecast
10.5.4 Turkey Point-of-care Infectious Disease Diagnostics Market Forecast
10.5.5 GCC Countries Point-of-care Infectious Disease Diagnostics Market Forecast
10.6 Global Point-of-care Infectious Disease Diagnostics Forecast by Type (2025-2030)
10.7 Global Point-of-care Infectious Disease Diagnostics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Product Offered
11.1.3 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Abbott
11.2.1 Abbott Company Information
11.2.2 Abbott Point-of-care Infectious Disease Diagnostics Product Offered
11.2.3 Abbott Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Abbott Main Business Overview
11.2.5 Abbott Latest Developments
11.3 Calypte Biomedical
11.3.1 Calypte Biomedical Company Information
11.3.2 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Product Offered
11.3.3 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Calypte Biomedical Main Business Overview
11.3.5 Calypte Biomedical Latest Developments
11.4 Chembio Diagnostic Systems
11.4.1 Chembio Diagnostic Systems Company Information
11.4.2 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Product Offered
11.4.3 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Chembio Diagnostic Systems Main Business Overview
11.4.5 Chembio Diagnostic Systems Latest Developments
11.5 Meridian Bioscience
11.5.1 Meridian Bioscience Company Information
11.5.2 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Product Offered
11.5.3 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Meridian Bioscience Main Business Overview
11.5.5 Meridian Bioscience Latest Developments
11.6 MedMira
11.6.1 MedMira Company Information
11.6.2 MedMira Point-of-care Infectious Disease Diagnostics Product Offered
11.6.3 MedMira Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 MedMira Main Business Overview
11.6.5 MedMira Latest Developments
11.7 Trinity Biotech
11.7.1 Trinity Biotech Company Information
11.7.2 Trinity Biotech Point-of-care Infectious Disease Diagnostics Product Offered
11.7.3 Trinity Biotech Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Trinity Biotech Main Business Overview
11.7.5 Trinity Biotech Latest Developments
11.8 Sekisui Diagnostics
11.8.1 Sekisui Diagnostics Company Information
11.8.2 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Product Offered
11.8.3 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Sekisui Diagnostics Main Business Overview
11.8.5 Sekisui Diagnostics Latest Developments
11.9 OraSure Technologies
11.9.1 OraSure Technologies Company Information
11.9.2 OraSure Technologies Point-of-care Infectious Disease Diagnostics Product Offered
11.9.3 OraSure Technologies Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 OraSure Technologies Main Business Overview
11.9.5 OraSure Technologies Latest Developments
11.10 Quidel
11.10.1 Quidel Company Information
11.10.2 Quidel Point-of-care Infectious Disease Diagnostics Product Offered
11.10.3 Quidel Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Quidel Main Business Overview
11.10.5 Quidel Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Point-of-care Infectious Disease Diagnostics Market Size 2019-2030
2.1.2 Point-of-care Infectious Disease Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Point-of-care Infectious Disease Diagnostics Segment by Type
2.2.1 HIV POC
2.2.2 Clostridium Difficile POC
2.2.3 HBV POC
2.2.4 Respiratory Syncytial Virus POC
2.2.5 HPV POC
2.2.6 Influenza/Flu POC
2.2.7 HCV POC
2.2.8 MRSA POC
2.2.9 TB and Drug-Resistant TB POC
2.3 Point-of-care Infectious Disease Diagnostics Market Size by Type
2.3.1 Point-of-care Infectious Disease Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Point-of-care Infectious Disease Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Home
2.4.4 Assisted Living Healthcare Facilities
2.4.5 Laboratories
2.4.6 Others
2.5 Point-of-care Infectious Disease Diagnostics Market Size by Application
2.5.1 Point-of-care Infectious Disease Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2019-2024)
3 POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Point-of-care Infectious Disease Diagnostics Market Size Market Share by Players
3.1.1 Global Point-of-care Infectious Disease Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Point-of-care Infectious Disease Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS BY REGIONS
4.1 Point-of-care Infectious Disease Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Point-of-care Infectious Disease Diagnostics Market Size Growth (2019-2024)
4.3 APAC Point-of-care Infectious Disease Diagnostics Market Size Growth (2019-2024)
4.4 Europe Point-of-care Infectious Disease Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024)
5.2 Americas Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024)
5.3 Americas Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point-of-care Infectious Disease Diagnostics Market Size by Region (2019-2024)
6.2 APAC Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024)
6.3 APAC Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Point-of-care Infectious Disease Diagnostics by Country (2019-2024)
7.2 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024)
7.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST
10.1 Global Point-of-care Infectious Disease Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Point-of-care Infectious Disease Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Point-of-care Infectious Disease Diagnostics Forecast
10.1.3 APAC Point-of-care Infectious Disease Diagnostics Forecast
10.1.4 Europe Point-of-care Infectious Disease Diagnostics Forecast
10.1.5 Middle East & Africa Point-of-care Infectious Disease Diagnostics Forecast
10.2 Americas Point-of-care Infectious Disease Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Point-of-care Infectious Disease Diagnostics Market Forecast
10.2.2 Canada Point-of-care Infectious Disease Diagnostics Market Forecast
10.2.3 Mexico Point-of-care Infectious Disease Diagnostics Market Forecast
10.2.4 Brazil Point-of-care Infectious Disease Diagnostics Market Forecast
10.3 APAC Point-of-care Infectious Disease Diagnostics Forecast by Region (2025-2030)
10.3.1 China Point-of-care Infectious Disease Diagnostics Market Forecast
10.3.2 Japan Point-of-care Infectious Disease Diagnostics Market Forecast
10.3.3 Korea Point-of-care Infectious Disease Diagnostics Market Forecast
10.3.4 Southeast Asia Point-of-care Infectious Disease Diagnostics Market Forecast
10.3.5 India Point-of-care Infectious Disease Diagnostics Market Forecast
10.3.6 Australia Point-of-care Infectious Disease Diagnostics Market Forecast
10.4 Europe Point-of-care Infectious Disease Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Point-of-care Infectious Disease Diagnostics Market Forecast
10.4.2 France Point-of-care Infectious Disease Diagnostics Market Forecast
10.4.3 UK Point-of-care Infectious Disease Diagnostics Market Forecast
10.4.4 Italy Point-of-care Infectious Disease Diagnostics Market Forecast
10.4.5 Russia Point-of-care Infectious Disease Diagnostics Market Forecast
10.5 Middle East & Africa Point-of-care Infectious Disease Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Point-of-care Infectious Disease Diagnostics Market Forecast
10.5.2 South Africa Point-of-care Infectious Disease Diagnostics Market Forecast
10.5.3 Israel Point-of-care Infectious Disease Diagnostics Market Forecast
10.5.4 Turkey Point-of-care Infectious Disease Diagnostics Market Forecast
10.5.5 GCC Countries Point-of-care Infectious Disease Diagnostics Market Forecast
10.6 Global Point-of-care Infectious Disease Diagnostics Forecast by Type (2025-2030)
10.7 Global Point-of-care Infectious Disease Diagnostics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Product Offered
11.1.3 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Abbott
11.2.1 Abbott Company Information
11.2.2 Abbott Point-of-care Infectious Disease Diagnostics Product Offered
11.2.3 Abbott Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Abbott Main Business Overview
11.2.5 Abbott Latest Developments
11.3 Calypte Biomedical
11.3.1 Calypte Biomedical Company Information
11.3.2 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Product Offered
11.3.3 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Calypte Biomedical Main Business Overview
11.3.5 Calypte Biomedical Latest Developments
11.4 Chembio Diagnostic Systems
11.4.1 Chembio Diagnostic Systems Company Information
11.4.2 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Product Offered
11.4.3 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Chembio Diagnostic Systems Main Business Overview
11.4.5 Chembio Diagnostic Systems Latest Developments
11.5 Meridian Bioscience
11.5.1 Meridian Bioscience Company Information
11.5.2 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Product Offered
11.5.3 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Meridian Bioscience Main Business Overview
11.5.5 Meridian Bioscience Latest Developments
11.6 MedMira
11.6.1 MedMira Company Information
11.6.2 MedMira Point-of-care Infectious Disease Diagnostics Product Offered
11.6.3 MedMira Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 MedMira Main Business Overview
11.6.5 MedMira Latest Developments
11.7 Trinity Biotech
11.7.1 Trinity Biotech Company Information
11.7.2 Trinity Biotech Point-of-care Infectious Disease Diagnostics Product Offered
11.7.3 Trinity Biotech Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Trinity Biotech Main Business Overview
11.7.5 Trinity Biotech Latest Developments
11.8 Sekisui Diagnostics
11.8.1 Sekisui Diagnostics Company Information
11.8.2 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Product Offered
11.8.3 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Sekisui Diagnostics Main Business Overview
11.8.5 Sekisui Diagnostics Latest Developments
11.9 OraSure Technologies
11.9.1 OraSure Technologies Company Information
11.9.2 OraSure Technologies Point-of-care Infectious Disease Diagnostics Product Offered
11.9.3 OraSure Technologies Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 OraSure Technologies Main Business Overview
11.9.5 OraSure Technologies Latest Developments
11.10 Quidel
11.10.1 Quidel Company Information
11.10.2 Quidel Point-of-care Infectious Disease Diagnostics Product Offered
11.10.3 Quidel Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Quidel Main Business Overview
11.10.5 Quidel Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Point-of-care Infectious Disease Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of HIV POC
Table 3. Major Players of Clostridium Difficile POC
Table 4. Major Players of HBV POC
Table 5. Major Players of Respiratory Syncytial Virus POC
Table 6. Major Players of HPV POC
Table 7. Major Players of Influenza/Flu POC
Table 8. Major Players of HCV POC
Table 9. Major Players of MRSA POC
Table 10. Major Players of TB and Drug-Resistant TB POC
Table 11. Point-of-care Infectious Disease Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 13. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2019-2024)
Table 14. Point-of-care Infectious Disease Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 15. Global Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 16. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2019-2024)
Table 17. Global Point-of-care Infectious Disease Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 18. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Player (2019-2024)
Table 19. Point-of-care Infectious Disease Diagnostics Key Players Head office and Products Offered
Table 20. Point-of-care Infectious Disease Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 21. New Products and Potential Entrants
Table 22. Mergers & Acquisitions, Expansion
Table 23. Global Point-of-care Infectious Disease Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 24. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Regions (2019-2024)
Table 25. Global Point-of-care Infectious Disease Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 26. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 27. Americas Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 28. Americas Point-of-care Infectious Disease Diagnostics Market Size Market Share by Country (2019-2024)
Table 29. Americas Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 30. Americas Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2019-2024)
Table 31. Americas Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 32. Americas Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2019-2024)
Table 33. APAC Point-of-care Infectious Disease Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 34. APAC Point-of-care Infectious Disease Diagnostics Market Size Market Share by Region (2019-2024)
Table 35. APAC Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 36. APAC Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2019-2024)
Table 37. APAC Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 38. APAC Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2019-2024)
Table 39. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 40. Europe Point-of-care Infectious Disease Diagnostics Market Size Market Share by Country (2019-2024)
Table 41. Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Europe Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2019-2024)
Table 43. Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Europe Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2019-2024)
Table 45. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Market Share by Region (2019-2024)
Table 47. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 48. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2019-2024)
Table 49. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 50. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2019-2024)
Table 51. Key Market Drivers & Growth Opportunities of Point-of-care Infectious Disease Diagnostics
Table 52. Key Market Challenges & Risks of Point-of-care Infectious Disease Diagnostics
Table 53. Key Industry Trends of Point-of-care Infectious Disease Diagnostics
Table 54. Global Point-of-care Infectious Disease Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 55. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 56. Global Point-of-care Infectious Disease Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 57. Global Point-of-care Infectious Disease Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 58. Thermo Fisher Scientific Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 59. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Product Offered
Table 60. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Thermo Fisher Scientific Main Business
Table 62. Thermo Fisher Scientific Latest Developments
Table 63. Abbott Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 64. Abbott Point-of-care Infectious Disease Diagnostics Product Offered
Table 65. Abbott Main Business
Table 66. Abbott Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Abbott Latest Developments
Table 68. Calypte Biomedical Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 69. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Product Offered
Table 70. Calypte Biomedical Main Business
Table 71. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Calypte Biomedical Latest Developments
Table 73. Chembio Diagnostic Systems Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 74. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Product Offered
Table 75. Chembio Diagnostic Systems Main Business
Table 76. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Chembio Diagnostic Systems Latest Developments
Table 78. Meridian Bioscience Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 79. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Product Offered
Table 80. Meridian Bioscience Main Business
Table 81. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Meridian Bioscience Latest Developments
Table 83. MedMira Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 84. MedMira Point-of-care Infectious Disease Diagnostics Product Offered
Table 85. MedMira Main Business
Table 86. MedMira Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. MedMira Latest Developments
Table 88. Trinity Biotech Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 89. Trinity Biotech Point-of-care Infectious Disease Diagnostics Product Offered
Table 90. Trinity Biotech Main Business
Table 91. Trinity Biotech Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Trinity Biotech Latest Developments
Table 93. Sekisui Diagnostics Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 94. Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Product Offered
Table 95. Sekisui Diagnostics Main Business
Table 96. Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Sekisui Diagnostics Latest Developments
Table 98. OraSure Technologies Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 99. OraSure Technologies Point-of-care Infectious Disease Diagnostics Product Offered
Table 100. OraSure Technologies Main Business
Table 101. OraSure Technologies Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. OraSure Technologies Latest Developments
Table 103. Quidel Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 104. Quidel Point-of-care Infectious Disease Diagnostics Product Offered
Table 105. Quidel Main Business
Table 106. Quidel Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Quidel Latest Developments
Table 1. Point-of-care Infectious Disease Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of HIV POC
Table 3. Major Players of Clostridium Difficile POC
Table 4. Major Players of HBV POC
Table 5. Major Players of Respiratory Syncytial Virus POC
Table 6. Major Players of HPV POC
Table 7. Major Players of Influenza/Flu POC
Table 8. Major Players of HCV POC
Table 9. Major Players of MRSA POC
Table 10. Major Players of TB and Drug-Resistant TB POC
Table 11. Point-of-care Infectious Disease Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 13. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2019-2024)
Table 14. Point-of-care Infectious Disease Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 15. Global Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 16. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2019-2024)
Table 17. Global Point-of-care Infectious Disease Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 18. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Player (2019-2024)
Table 19. Point-of-care Infectious Disease Diagnostics Key Players Head office and Products Offered
Table 20. Point-of-care Infectious Disease Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 21. New Products and Potential Entrants
Table 22. Mergers & Acquisitions, Expansion
Table 23. Global Point-of-care Infectious Disease Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 24. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Regions (2019-2024)
Table 25. Global Point-of-care Infectious Disease Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 26. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 27. Americas Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 28. Americas Point-of-care Infectious Disease Diagnostics Market Size Market Share by Country (2019-2024)
Table 29. Americas Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 30. Americas Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2019-2024)
Table 31. Americas Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 32. Americas Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2019-2024)
Table 33. APAC Point-of-care Infectious Disease Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 34. APAC Point-of-care Infectious Disease Diagnostics Market Size Market Share by Region (2019-2024)
Table 35. APAC Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 36. APAC Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2019-2024)
Table 37. APAC Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 38. APAC Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2019-2024)
Table 39. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 40. Europe Point-of-care Infectious Disease Diagnostics Market Size Market Share by Country (2019-2024)
Table 41. Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Europe Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2019-2024)
Table 43. Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Europe Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2019-2024)
Table 45. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Market Share by Region (2019-2024)
Table 47. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 48. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2019-2024)
Table 49. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 50. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2019-2024)
Table 51. Key Market Drivers & Growth Opportunities of Point-of-care Infectious Disease Diagnostics
Table 52. Key Market Challenges & Risks of Point-of-care Infectious Disease Diagnostics
Table 53. Key Industry Trends of Point-of-care Infectious Disease Diagnostics
Table 54. Global Point-of-care Infectious Disease Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 55. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 56. Global Point-of-care Infectious Disease Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 57. Global Point-of-care Infectious Disease Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 58. Thermo Fisher Scientific Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 59. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Product Offered
Table 60. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Thermo Fisher Scientific Main Business
Table 62. Thermo Fisher Scientific Latest Developments
Table 63. Abbott Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 64. Abbott Point-of-care Infectious Disease Diagnostics Product Offered
Table 65. Abbott Main Business
Table 66. Abbott Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Abbott Latest Developments
Table 68. Calypte Biomedical Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 69. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Product Offered
Table 70. Calypte Biomedical Main Business
Table 71. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Calypte Biomedical Latest Developments
Table 73. Chembio Diagnostic Systems Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 74. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Product Offered
Table 75. Chembio Diagnostic Systems Main Business
Table 76. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Chembio Diagnostic Systems Latest Developments
Table 78. Meridian Bioscience Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 79. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Product Offered
Table 80. Meridian Bioscience Main Business
Table 81. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Meridian Bioscience Latest Developments
Table 83. MedMira Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 84. MedMira Point-of-care Infectious Disease Diagnostics Product Offered
Table 85. MedMira Main Business
Table 86. MedMira Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. MedMira Latest Developments
Table 88. Trinity Biotech Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 89. Trinity Biotech Point-of-care Infectious Disease Diagnostics Product Offered
Table 90. Trinity Biotech Main Business
Table 91. Trinity Biotech Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Trinity Biotech Latest Developments
Table 93. Sekisui Diagnostics Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 94. Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Product Offered
Table 95. Sekisui Diagnostics Main Business
Table 96. Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Sekisui Diagnostics Latest Developments
Table 98. OraSure Technologies Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 99. OraSure Technologies Point-of-care Infectious Disease Diagnostics Product Offered
Table 100. OraSure Technologies Main Business
Table 101. OraSure Technologies Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. OraSure Technologies Latest Developments
Table 103. Quidel Details, Company Type, Point-of-care Infectious Disease Diagnostics Area Served and Its Competitors
Table 104. Quidel Point-of-care Infectious Disease Diagnostics Product Offered
Table 105. Quidel Main Business
Table 106. Quidel Point-of-care Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Quidel Latest Developments
LIST OF FIGURES
Figure 1. Point-of-care Infectious Disease Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Point-of-care Infectious Disease Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Point-of-care Infectious Disease Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. Point-of-care Infectious Disease Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type in 2023
Figure 10. Point-of-care Infectious Disease Diagnostics in Hospitals
Figure 11. Global Point-of-care Infectious Disease Diagnostics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Point-of-care Infectious Disease Diagnostics in Clinics
Figure 13. Global Point-of-care Infectious Disease Diagnostics Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Point-of-care Infectious Disease Diagnostics in Home
Figure 15. Global Point-of-care Infectious Disease Diagnostics Market: Home (2019-2024) & ($ Millions)
Figure 16. Point-of-care Infectious Disease Diagnostics in Assisted Living Healthcare Facilities
Figure 17. Global Point-of-care Infectious Disease Diagnostics Market: Assisted Living Healthcare Facilities (2019-2024) & ($ Millions)
Figure 18. Point-of-care Infectious Disease Diagnostics in Laboratories
Figure 19. Global Point-of-care Infectious Disease Diagnostics Market: Laboratories (2019-2024) & ($ Millions)
Figure 20. Point-of-care Infectious Disease Diagnostics in Others
Figure 21. Global Point-of-care Infectious Disease Diagnostics Market: Others (2019-2024) & ($ Millions)
Figure 22. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application in 2023
Figure 23. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Player in 2023
Figure 24. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Point-of-care Infectious Disease Diagnostics Market Size 2019-2024 ($ Millions)
Figure 26. APAC Point-of-care Infectious Disease Diagnostics Market Size 2019-2024 ($ Millions)
Figure 27. Europe Point-of-care Infectious Disease Diagnostics Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size 2019-2024 ($ Millions)
Figure 29. Americas Point-of-care Infectious Disease Diagnostics Value Market Share by Country in 2023
Figure 30. United States Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Point-of-care Infectious Disease Diagnostics Market Size Market Share by Region in 2023
Figure 35. APAC Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type in 2023
Figure 36. APAC Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application in 2023
Figure 37. China Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Point-of-care Infectious Disease Diagnostics Market Size Market Share by Country in 2023
Figure 44. Europe Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2019-2024)
Figure 45. Europe Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2019-2024)
Figure 46. Germany Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. APAC Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. Europe Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. United States Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Canada Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. China Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. Japan Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. Korea Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. India Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. Australia Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Germany Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. France Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. UK Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. Italy Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. Russia Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. Spain Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 81. Israel Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 84. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Point-of-care Infectious Disease Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Point-of-care Infectious Disease Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Point-of-care Infectious Disease Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. Point-of-care Infectious Disease Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type in 2023
Figure 10. Point-of-care Infectious Disease Diagnostics in Hospitals
Figure 11. Global Point-of-care Infectious Disease Diagnostics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Point-of-care Infectious Disease Diagnostics in Clinics
Figure 13. Global Point-of-care Infectious Disease Diagnostics Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Point-of-care Infectious Disease Diagnostics in Home
Figure 15. Global Point-of-care Infectious Disease Diagnostics Market: Home (2019-2024) & ($ Millions)
Figure 16. Point-of-care Infectious Disease Diagnostics in Assisted Living Healthcare Facilities
Figure 17. Global Point-of-care Infectious Disease Diagnostics Market: Assisted Living Healthcare Facilities (2019-2024) & ($ Millions)
Figure 18. Point-of-care Infectious Disease Diagnostics in Laboratories
Figure 19. Global Point-of-care Infectious Disease Diagnostics Market: Laboratories (2019-2024) & ($ Millions)
Figure 20. Point-of-care Infectious Disease Diagnostics in Others
Figure 21. Global Point-of-care Infectious Disease Diagnostics Market: Others (2019-2024) & ($ Millions)
Figure 22. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application in 2023
Figure 23. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Player in 2023
Figure 24. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Point-of-care Infectious Disease Diagnostics Market Size 2019-2024 ($ Millions)
Figure 26. APAC Point-of-care Infectious Disease Diagnostics Market Size 2019-2024 ($ Millions)
Figure 27. Europe Point-of-care Infectious Disease Diagnostics Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size 2019-2024 ($ Millions)
Figure 29. Americas Point-of-care Infectious Disease Diagnostics Value Market Share by Country in 2023
Figure 30. United States Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Point-of-care Infectious Disease Diagnostics Market Size Market Share by Region in 2023
Figure 35. APAC Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type in 2023
Figure 36. APAC Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application in 2023
Figure 37. China Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Point-of-care Infectious Disease Diagnostics Market Size Market Share by Country in 2023
Figure 44. Europe Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2019-2024)
Figure 45. Europe Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2019-2024)
Figure 46. Germany Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Point-of-care Infectious Disease Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. APAC Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. Europe Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. United States Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Canada Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. China Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. Japan Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. Korea Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. India Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. Australia Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Germany Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. France Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. UK Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. Italy Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. Russia Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. Spain Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 81. Israel Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Point-of-care Infectious Disease Diagnostics Market Size 2025-2030 ($ Millions)
Figure 84. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Point-of-care Infectious Disease Diagnostics Market Size Market Share Forecast by Application (2025-2030)
